GLP-1 Drugs Cut Uterine Cancer Risk by 66%
Women taking Ozempic-type drugs with hormone therapy slashed their uterine cancer risk by two-thirds compared to hormones alone. The discovery could spare thousands from surgery and offer new protection against the most common gynecologic cancer.